Tetrahydrofuran → {[7-(3-Chlorophenyl)-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl]methyl}carbamic azide
反応式
[Cl:1][C:2]1[CH:3]=[C:4]([C:8]2[CH:9]=[C:10]3[C:15](=[O:16])[NH:14][CH2:13][CH:12]([CH2:17]C(O)=O)[N:11]3[CH:21]=2)[CH:5]=[CH:6][CH:7]=1.[N-:22]=[N+:23]=[N-:24].[Na+].C1C=CC(P([N:40]=[N+]=[N-])(C2C=CC=CC=2)=O)=CC=1.C1[CH2:47][O:46]CC1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:8]2[CH:9]=[C:10]3[C:15](=[O:16])[NH:14][CH2:13][CH:12]([CH2:17][NH:40][C:47]([N:22]=[N+:23]=[N-:24])=[O:46])[N:11]3[CH:21]=2)[CH:5]=[CH:6][CH:7]=1参加物
5
実験手順
100 mg (0.328 mmol) of [7-(3-chlorophenyl)-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl]acetic acid and NaN3 (664 mg, 0.98 mmol) were suspended in 10 ml of dry THF, 108 mg of DPPA (0.394 mmol) was added. The mixture was stirred at room temperature for 18 h. The volatiles were removed under vacuo and the residue was purified by flash chromatography (DCM/EtOAc/EtOH 6/3/1) to give the desired compound and a secondary compound.
後処理
- customThe volatiles were removed under vacuo
- customthe residue was purified by flash chromatography (DCM/EtOAc/EtOH 6/3/1)
出典と根拠
- ORDレコード
- ord-af6b37648428426d9d473f99bfa879ec
- 出典データセット
- uspto-grants-2015_11
- 特許番号
- US09181258B2
反応ノート
読み込み中…